New antimalarial more effective than current treatment, but no improvement in adverse birth outcomes
A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.
Mar 13, 2023
0
72
